Form 8-K - Current report:
SEC Accession No. 0001641172-25-004320
Filing Date
2025-04-14
Accepted
2025-04-14 14:27:42
Documents
15
Period of Report
2025-04-14
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42522
2 ex16-1.htm EX-16.1 5038
  Complete submission text file 0001641172-25-004320.txt   225601

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE envb-20250414.xsd EX-101.SCH 3012
4 XBRL LABEL FILE envb-20250414_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE envb-20250414_pre.xml EX-101.PRE 22357
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3827
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 25835508
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)